However, frequent secondary lesions in ETV6::RUNX1-positive ALL may directly affect the glucocorticoid response (e.g., by mutation of the glucocorticoid receptor NR3C1), the cell death pathway induced via its signaling, or components of the mismatch repair pathways [39]. This evidence concerns the gene RUNX1 and acute lymphoblastic leukemia.